Literature DB >> 26407855

The multimerization and secretion of adiponectin are regulated by TNF-alpha.

Yiduo He1, Linfang Lu1, Xuan Wei1, Dan Jin1, Tao Qian1, An Yu1, Jun Sun1, Jiesheng Cui1, Zaiqing Yang2.   

Abstract

Obesity is often associated with insulin resistance, mild systemic inflammation, and decreased blood adiponectin. However, some adipokines are increased in the adipose tissue of obese individuals, and whether these adipokines are directly related to the reductions in serum adiponectin levels in an autocrine or paracrine manner remains unknown. This study indicates that the tumor necrosis factor alpha (TNF-α) suppresses the multimerization and secretion of adiponectin both in vitro and in vivo. Additionally, TNF-α remarkably suppressed the expression of the ER-resident chaperone proteins ERO1-La, DsbA-L, and ERp44. Overexpression of the transcription factor PPARγ antagonized the suppressive effect of TNF-α on ERO1-La and DsbA-L expressions. Further study revealed that PPARγ enhanced the transcription of ERO1-La and DsbA-L by directly binding to the PPRE element of ERO1-La and DsbA-L promoters. TNF-α treatment decreased this binding activity. Furthermore, TNF-α treatment enhanced the interaction between adiponectin and ERp44. In this study, we show that TNF-α impairs adiponectin multimerization and consequently decreases adiponectin secretion by altering disulfide bond modification in the endoplasmic reticulum. Altered adiponectin multimerization could explain declined adiponectin levels and altered distribution of adiponectin complexes in the plasma of obese insulin-resistant individuals.

Entities:  

Keywords:  Adiponectin; Multimerization; Obesity; PPARγ; Secretion

Mesh:

Substances:

Year:  2015        PMID: 26407855     DOI: 10.1007/s12020-015-0741-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

1.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

2.  Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue.

Authors:  D Konrad; A Rudich; E J Schoenle
Journal:  Diabetologia       Date:  2007-02-16       Impact factor: 10.122

3.  c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.

Authors:  Kun-yong Kim; Jae Kwang Kim; Jun Ho Jeon; Suk Ran Yoon; Inpyo Choi; Young Yang
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

4.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

5.  Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha.

Authors:  Li Qiang; Hong Wang; Stephen R Farmer
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

6.  Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.

Authors:  Aina S Lihn; Bjørn Richelsen; Steen B Pedersen; Steen B Haugaard; Gulla Søby Rathje; Sten Madsbad; Ove Andersen
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-07-22       Impact factor: 4.310

7.  Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications.

Authors:  Ayanthi A Richards; Tim Stephens; Hayley K Charlton; Alun Jones; Graeme A Macdonald; Johannes B Prins; Jonathan P Whitehead
Journal:  Mol Endocrinol       Date:  2006-02-23

Review 8.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.

Authors:  E Maury; S M Brichard
Journal:  Mol Cell Endocrinol       Date:  2009-08-12       Impact factor: 4.102

9.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.

Authors:  Philip A Kern; Gina B Di Gregorio; Tong Lu; Negah Rassouli; Gouri Ranganathan
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  19 in total

1.  Role of adiponectin in the metabolism of skeletal muscles in collagen VI-related myopathies.

Authors:  Tania Gamberi; Francesca Magherini; Michele Mannelli; Martina Chrisam; Matilde Cescon; Silvia Castagnaro; Alessandra Modesti; Paola Braghetta; Tania Fiaschi
Journal:  J Mol Med (Berl)       Date:  2019-03-29       Impact factor: 4.599

2.  Loss of DBC1 (CCAR2) affects TNFα-induced lipolysis and Glut4 gene expression in murine adipocytes.

Authors:  Ashley A Able; Allison J Richard; Jacqueline M Stephens
Journal:  J Mol Endocrinol       Date:  2018-10-15       Impact factor: 5.098

3.  Impact of Intragastric Balloon Treatment on Adipokines, Cytokines, and Metabolic Profile in Obese Individuals.

Authors:  Marcella Rodrigues Guedes; Ricardo José Fittipaldi-Fernandez; Cristina Fajardo Diestel; Márcia Regina Simas Torres Klein
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  Postprandial activation of leukocyte-endothelium interaction by fatty acids in the visceral adipose tissue microcirculation.

Authors:  Kyle J Preston; Inna Rom; Christine Vrakas; Gavin Landesberg; Zienab Etwebi; Sanae Muraoka; Michael Autieri; Satoru Eguchi; Rosario Scalia
Journal:  FASEB J       Date:  2019-08-08       Impact factor: 5.191

5.  Positive Effects of Extra-Virgin Olive Oil Supplementation and DietBra on Inflammation and Glycemic Profiles in Adults With Type 2 Diabetes and Class II/III Obesity: A Randomized Clinical Trial.

Authors:  Erika Aparecida Silveira; Lorena Pereira de Souza Rosa; Danilo Pires de Resende; Ana Paula Dos Santos Rodrigues; Adeliane Castro da Costa; Andréa Toledo de Oliveira Rezende; Matias Noll; Cesar de Oliveira; Ana Paula Junqueira-Kipnis
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

Review 6.  Dyslipidemia: Obese or Not Obese-That Is Not the Question.

Authors:  David H Ipsen; Pernille Tveden-Nyborg; Jens Lykkesfeldt
Journal:  Curr Obes Rep       Date:  2016-12

Review 7.  Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation.

Authors:  Rosa Divella; Raffaele De Luca; Ines Abbate; Emanuele Naglieri; Antonella Daniele
Journal:  J Cancer       Date:  2016-11-26       Impact factor: 4.207

8.  ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer.

Authors:  Rosa Divella; Antonella Daniele; Antonio Mazzocca; Ines Abbate; Porzia Casamassima; Cosimo Caliandro; Eustachio Ruggeri; Emanuele Naglieri; Carlo Sabbà; Raffaele De Luca
Journal:  J Cancer       Date:  2017-03-25       Impact factor: 4.207

9.  A genetic analysis identifies a haplotype at adiponectin locus: Association with obesity and type 2 diabetes.

Authors:  Roma Patel; Shahnawaz D Jadeja; Sayantani Pramanik Palit; Nirali Rathwa; Ankit Mahajan; A V Ramachandran; Manoj K Dhar; Swarkar Sharma; Rasheedunnisa Begum
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

10.  Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy.

Authors:  Rita Polito; Ersilia Nigro; Antonio Pecoraro; Maria Ludovica Monaco; Franco Perna; Alessandro Sanduzzi; Arturo Genovese; Giuseppe Spadaro; Aurora Daniele
Journal:  Front Immunol       Date:  2019-11-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.